ciglitazone has been researched along with Carcinoma, Non-Small Cell Lung in 7 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciglitazone treatment suppressed COX-2 mRNA expression and COX-2 promoter activity while upregulating PPRE promoter activity." | 1.34 | Ciglitazone mediates COX-2 dependent suppression of PGE2 in human non-small cell lung cancer cells. ( Dubinett, SM; Hazra, S, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, TW | 1 |
| Hong, DW | 1 |
| Park, JW | 1 |
| Hong, SH | 2 |
| Hann, SS | 1 |
| Tang, Q | 1 |
| Zheng, F | 1 |
| Zhao, S | 1 |
| Chen, J | 1 |
| Wang, Z | 1 |
| Yoshizaki, T | 1 |
| Motomura, W | 1 |
| Tanno, S | 2 |
| Kumei, S | 1 |
| Yoshizaki, Y | 1 |
| Okumura, T | 1 |
| Wang, JJ | 1 |
| Mak, OT | 1 |
| Han, EJ | 1 |
| Im, CN | 1 |
| Park, SH | 1 |
| Moon, EY | 1 |
| Hazra, S | 1 |
| Dubinett, SM | 1 |
| Chang, TH | 1 |
| Szabo, E | 1 |
7 other studies available for ciglitazone and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
CB11, a novel purine-based PPARɣ ligand, overcomes radio-resistance by regulating ATM signalling and EMT in human non-small-cell lung cancer cells.
Topics: 3T3 Cells; Adipocytes; Anilides; Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Azo Com | 2020 |
Repression of phosphoinositide-dependent protein kinase 1 expression by ciglitazone via Egr-1 represents a new approach for inhibition of lung cancer cell growth.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; AMP-Activated Protein Kinases; Apoptosis; Carcinoma, N | 2014 |
Thiazolidinediones enhance vascular endothelial growth factor expression and induce cell growth inhibition in non-small-cell lung cancer cells.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Culture Media; Humans; Hypogly | 2010 |
Induction of apoptosis by 15d-PGJ2 via ROS formation: an alternative pathway without PPARγ activation in non-small cell lung carcinoma A549 cells.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspases; Cell Line, Tumor; Glutathione; Humans; Lung Neo | 2011 |
Combined treatment with peroxisome proliferator-activated receptor (PPAR) gamma ligands and gamma radiation induces apoptosis by PPARγ-independent up-regulation of reactive oxygen species-induced deoxyribonucleic acid damage signals in non-small cell lung
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspase 3; Caspase 8; DNA Damage; Fluoresceins; Gamma Ray | 2013 |
Ciglitazone mediates COX-2 dependent suppression of PGE2 in human non-small cell lung cancer cells.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cyclooxygenase 2; Dinoprostone; Humans; Hydroxypro | 2007 |
Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung.
Topics: Adenocarcinoma; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Blotting, Western; Carc | 2002 |